GSK is committed to improve the quality of life by offering people the chance to do more, feel better and live longer.


For GSK, how we deliver success is just as important as what we achieve. Ensuring our values are embedded in our business is a priority. In September 2018, we announced that we are investing in a new set of commitments across three focus areas, to deliver the greatest possible long-term impact in improving health around the world.

New medical innovations

Develop differentiated, high-quality and needed medicines, vaccines and consumer healthcare products to improve health

Global health

Improve global health impact through R&D for infectious diseases that affect children and adolescents in developing countries focusing on HIV, malaria and TB

Health security

Help the world to better prepare for future disease outbreaks with pandemic potential, and tackle antimicrobial resistance

How we will report our performance

We will share our progress by reporting against our new commitments each year starting in 2019, for the 2018 year.

For our 2017 responsible business reporting, please see our Responsible Business Supplement alongside our financial performance within the Annual Report.